Member Info for Parob

‘We aim to become the biggest video game advertising media owner in the world’- Bidstack’s CEO James Draper discusses his firm’s ‘once in a lifetime’ opportunity.

https://www.valuethemarkets.com/2019/04/12/we-aim-to-become-the-biggest-video-game-advertising-media-owner-in-the-world-bidstacks-ceo-james-draper-discusses-his-firms-once-in-a-lifetime-op/

12 APR 2019

The following quote was BEFORE Google Stadia was even in the picture. Imagine the boost to numbers after today’s news. Football Manager is a launch game and comes with free publicity from Google Stadia:

“Around 150,000 people play Football Manager on a typical day, spending an average of four hours in the game per day. According to Bidstack, this generates around 25m potential impressions per day, giving the game an advertising inventory worth over £100m per year.”

Totally agree Belgrano.. I think we will see some FOMO kicking in over the coming days. Here’s the updated list of deals/revenue sources. Recent, current and potential future revenue streams confirmed: - GoFigure: shakes, bars and muesli pots - CholBiome (x3 and Daily Maintenance) - SlimBiome Medical (UK - through Optibiotix Online shop) - Sacco/CSL - HLH BioPharma Vertriebs GmbH - Nutrilinia (LD-LDL and Slimbiome Medical) - Pharmabiota - Galenicum Special Ingredients - Knighton Foods - Cereal Ingredients Inc. - Fine Foods & Pharmaceuticals - Trigen Pharma - Cambridge Commodities - Akums Drugs and Pharma - Seed Health - John Morley’s - Alfasigma - Unnamed global corporate ($100B+ turnover) for SweetBiotix manufacturing & distribution. - Unnamed US pharma partner (cholesterol strain) - Bened Biomedical - Bulgarian CholBiome distributor (Velinoff Pharma/Medochem) - CTC Group - Formulation Creations - US Pharma Lab Inc. - Unnamed Greece and Cyprus CholBiome distributor - Unnamed Greece and Cyprus SlimBiome Medical distributor - Zeon Lifesciences - SilvExpo - CholBiome - Biolat - RMS CardioPro - EIWA Trading Co. Ltd - DKSH - Unnamed Bulgarian distributor for SlimBiome Medical - 39ytu - IENP - Capsa Food (available in El Corte Inglés stores in Spain) - Primo Trading Revenue/deal not confirmed yet: - Tata X 2 (Slimbiome and LPGOS) - Mystery US Slimbiome customer - Paradise Fruits (Slimbiome) - global supplier of nutritional and agricultural products (annual turnover exceeding $100bn). - Beijing Duoite Biotechnology Co., Ltd (LP-LDL distributors via CSL) - US company to license OptiBiotix's high intensity derived sweeteners. - Global partner to jointly develop a finished product which allows claim for sugar and calorie reduction. Products on the market already but not RNSed: - MuscleForm (Aviform Ltd) - Ultra MR Ultimate Meal Replacement - Olliscience - Ollibiotic - Aragan - Biotic•P3

Elrico chat with Stuart Ashman just published:

https://lemminginvestors.blogspot.com/2019/05/skinbiotherapeutics-chat-with-stuart.html

https://lemminginvestors.blogspot.com/2019/05/optibiotix-health-fy-2018-explained-for.html I expect OPTI's SP to start its annual recover through May but suspect many will be caught napping because we have been blessed with great news which seemingly has had little to no effect on the SP for a prolonged period, no thanks to FinnCrap and or the short term traders pinching a few pennies into the rise; this cannot continue indefinitely, hence why I think traders will be caught out, or even caught short. I maintain £5 as my target by FY 2020.

Product is for sale already including pharmacies in some El Corte Ingles stores. Unlike many of the other deals, we don’t have to wait for the product launch with this agreement as the its already on the shelves, with revenue being received. hTTps://www.39ytu.com/soluciones-bioactivas/3/Reducir-tu-colesterol 39ytu have announced that they will now be stocking their products in El Corte Inglés stores in the following stores in Spain: Plaza Cataluña Diagonal Bilbao Las Palmas Goya Castellana Princesa Sanchinarro Campo de Las Naciones Pozuelo Málaga Murcia Now you have our nutrition products in the parapharmacies of El Corte Inglés .You can help your microbiota today from home or by going to one of these centers. Try our probiotic to relieve your intestinal transit , or in case you need it, control your cholesterol with our food with lactobacillus plantarum LP LDL and plant sterols. See: hTTps://www.39ytu.com/articulos/index.php/2019/04/26/ya-puedes-comprar-39ytu-en-la-parafarmacia-de-el-corte-ingles/ Here are their products on display in a El Corte Ingles: hTTps://mobile.twitter.com/javiercuervo/status/1121485456162664448

SlimBiome @slimbiome tweet: We're excited to share that we've received the first commercial order of SlimBiome for the Indian market! We're looking forward to continuously working with partners (new and old) in supplying science-backed and proven weight management across the globe.

Chapati for weight loss? OptiBiotix outlines Indian plans for SlimBiome after FSSAI approval 22-Apr-2019 at 03:19 https://www.nutraingredients-asia.com/Article/2019/04/22/Chapati-for-weight-loss-OptiBiotix-outlines-Indian-plans-for-SlimBiome-after-FSSAI-approval

I take it you have researched the New Non-Exec Mike Hayes who is Investment Director, Head of Digital & Digital Entertainment

At Mercia Technologies PLC

https://www.merciatech.co.uk/our-people/mike-hayes/
About

Mike is the Head of the Digital & Digital Entertainment sector, with over 30 years' experience in this industry. His main focus is to build a portfolio of digital media including gaming, virtual reality, mixed reality, augmented reality, middleware and trading platforms. He channels his expertise and experience into building a strong digital portfolio to support and mentor innovative young businesses.

There will be strong support of any placement.

https://lemminginvestors.blogspot.com/2019/03/optibiotix-health-plc-q-by-antz-at-uki OptitBiotix Health PLC (OPTI) bod was ready to meet and greet investors and potentials alike at the UKI show on Saturday. CEO. Stephen O'Hara made himself available for post-presentation chat. Also present, Executive Sales & Marketing Director Christina Wood, Research and Development Director Dr Sofia Kolyda and Managing Director, Fred Narbel - All of which were on-hand for investor queries. To this end, long term investor Antz aka Trotter's trading, who was good enough to speak at length with the team and compiled the following Q&A, which has been fact check by Stephen O'Hara.

BIDS featured on The Weekend Podcast, as we know Justin is a massive fan.

From 13 mins 57 seconds:

https://audioboom.com/posts/7217344-the-weekend-podcast

Few quotes:

“I genuine think this is going to be massive”

“They are trailblazing in so many different ways and I think there will be lots of news coming out”

“I genuinely think this is like a Versarien or EVRH but with a sustainable future and I see this in excess of a £100M market cap quite easily”

Sounds like he’s planning on doing another video on BIDS this weekend covering off what James Draper said in the podcast a few weeks ago.

Great to see CholBiomeX3 shortlisted in the 2019 NutraIngredients Awards under 'Probiotic product of the Year'. Event is on 8th May. https://www.nutraingredients.com/Article/2019/03/27/Who-made-the-final-NutraIngredients-Awards-shortlist-announced All helps in getting the name out there.

Commercial Update The Company has a strategy of creating interests and commercial agreements with multiple companies who have expertise in the manufacture and application development of high value speciality ingredients. This has led to agreements with two companies (RNS: 31 May 2018 and 26 June 2018) looking to explore the potential to reduce the sugar content in a range of applications, including dairy. In addition to ongoing discussion with existing partners, OptiBiotix has reached non-binding Heads of Terms with a US company to license OptiBiotix’s high intensity derived sweeteners. This company has funded the pilot scale up and supply of two batches of high intensity derived sweeteners. Once a binding commercial agreement has been reached, this will be announced to the market. Late stage discussions are ongoing with another global partner to jointly develop a finished product which allows claim for sugar and calorie reduction whilst limiting any cost increase in the final product to 10%.

Here’s a reminder of all those agreements. Recent, current and potential future revenue streams confirmed: - GoFigure: shakes, bars and muesli pots - CholBiome (x3 and Daily Maintenance) - Sacco/CSL - HLH BioPharma Vertriebs GmbH - Nutrilinia (LD-LDL and Slimbiome Medical) - Pharmabiota - Galenicum Special Ingredients - Knighton Foods - Cereal Ingredients Inc. - Fine Foods & Pharmaceuticals - Trigen Pharma - Cambridge Commodities - Akums Drugs and Pharma - Seed Health - John Morley’s - Alfasigma - Unnamed global corporate ($100B+ turnover) for SweetBiotix manufacturing & distribution. - Unnamed US pharma partner (cholesterol strain) - Bened Biomedical - Bulgarian CholBiome distributor (Velinoff Pharma/Medochem) - CTC Group - Formulation Creations - US Pharma Lab Inc. - Unnamed Greece and Cyprus CholBiome distributor - Unnamed Greece and Cyprus SlimBiome Medical distributor - Zeon Lifesciences - SilvExpo - CholBiome - Biolat - RMS CardioPro - EIWA Trading Co. Ltd - DKSH Revenue not confirmed yet: - Tata X 2 (Slimbiome and LPGOS) - Mystery US Slimbiome customer - Paradise Fruits (Slimbiome) - Beijing Duoite Biotechnology Co., Ltd (LP-LDL distributors via CSL) Products on the market already but not RNSed: - MuscleForm (Aviform Ltd) - Ultra MR Ultimate Meal Replacement - Olliscience - Ollibiotic - Aragan - Biotic•P3 - 39ytu - Capsa Food

...including new comment from SOH: https://lemminginvestors.blogspot.com/2019/03/optibiotix-oh-no-not-again.html?m=1

https://mobile.twitter.com/Parob17/status/1104831892375957504 Great find by 2011revolution in the twitter group. From the UK government website: https://www.gov.uk/government/news/minister-for-asia-mark-field-visited-india After New Delhi the Minister visited Mumbai where he met young entrepreneurs at the ‘Fintegrate Zone’ conference to further the UK’s position as a world leader in FinTech and position the UK as India’s partner of choice in raising finance. Among other engagements in Mumbai, he attended a MULTI-MILLION pound UK-India life sciences deal signing; promoted UK-India sports links in the run up to the 2019 Cricket World Cup; and interacted with Indian youth leaders and Chevening alumni.

From: @lemminginvestor New comment from SOH at the end of the blog: https://lemminginvestors.blogspot.com/2019/03/optibiotix-health-avoiding-kodak-moment.html

Tipped by Midas!

https://www.dailymail.co.uk/money/investing/article-6760447/MIDAS-SHARE-TIPS-Emmerson-harvesting-profit-fertiliser.html

MIDAS SHARE TIPS: Emmerson is harvesting profit from fertiliser as the world's population booms

Belgrano, I believe we are on the cusp of major rerate. The share price has been consolidating in an ever-tighter range since December and the 4 deals this year (2 large - Zeon & EIWA) and 2 major pieces of news this week are not yet priced in, but they will be very soon IMO. We are about to break North of the bullish flag that’s formed. I’m really looking forward to the stock market opening tomorrow. In the meantime here is the most updated list of partners/products/revenue streams: Recent, current and potential future revenue streams confirmed: - GoFigure: shakes, bars and muesli pots - CholBiome (x3 and Daily Maintenance) - Sacco/CSL - HLH BioPharma Vertriebs GmbH - Nutrilinia (LD-LDL and Slimbiome Medical) - Pharmabiota - Galenicum Special Ingredients - Knighton Foods - Cereal Ingredients Inc. - Fine Foods & Pharmaceuticals - Trigen Pharma - Cambridge Commodities - Akums Drugs and Pharma - Seed Health - John Morley’s - Alfasigma - Unnamed global corporate ($100B+ turnover) for SweetBiotix manufacturing & distribution. - Unnamed US pharma partner (cholesterol strain) - Bened Biomedical - Bulgarian CholBiome distributor (Velinoff Pharma/Medochem) - CTC Group - Formulation Creations - US Pharma Lab Inc. - Unnamed Greece and Cyprus CholBiome distributor - Unnamed Greece and Cyprus SlimBiome Medical distributor - Zeon Lifesciences - SilvExpo - CholBiome - Biolat - RMS CardioPro - EIWA Trading Co. Ltd Revenue not confirmed yet: - Tata X 2 (Slimbiome and LPGOS) - Mystery US Slimbiome customer - Paradise Fruits (Slimbiome) - Beijing Duoite Biotechnology Co., Ltd (LP-LDL distributors via CSL) Products on the market already but not RNSed: - MuscleForm (Aviform Ltd) - Ultra MR Ultimate Meal Replacement - Olliscience - Ollibiotic - Aragan - Biotic•P3 - 39ytu - Capsa Food

New interview https://tinyurl.com/y2cqsyn5 OptiBiotix cholesterol product 'generally recognised as safe' by US independent expert panel

http://tinyurl.com/y55yvcay 15:39 11 Feb 2019 Following hard on the heels of a commercial deal covering the Baltic area, OptiBiotix Health plc (LON:OPTI) has signed an agreement that will see its breakthrough cholesterol-lowering bacteria strain distributed in Japan. Founder and CEO Stephen O'Hara talks Proactive London through OptiBiotix's last two RNS's and explains how they are inter-related. O'Hara also explains how he has an eye for an emerging trend and how this product, in his view, is one of those key moments. For the UK group has negotiated an exclusive tie-up with the EIWA Trading Co for its LPLDL product. OptiBiotix will ship an agreed minimum volume of the cholesterol and blood pressure-reducing probiotic, Lactobacillus plantarum, which rises over the term of the three-year contract.